Fig. 16.1 Perforated appendiceal tumor [low-grade appendiceal mucinous neoplasms (LAMN II)] 16.3 Clinical Features PMP usually manifests with the characteristic jelly belly (Fig. 16.2) appearance, represented by the advanced stage…
Fig. 21.1 Proposed models for the development of types 1 and 2 tumors of the ovary. SCOUT, secretory cell outgrowths; P53, tumor protein 53; STIC, serous tubal intraepithelial carcinoma; PPSPC,…
Study Type of study Phase Time Drug Id number* Country Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First-Line Therapy Safety/efficacy…
Fig. Peritoneal Cancer Index (PCI) classification: Three-dimensional imaging simulation for PCI mapping and scoring. An imaging database can furnish all useful images to place the lesions; dedicated software calculates overall…
Fig. 11.1 Peritoneal Cancer Index (PCI) scoring system 11.4 Defining Completeness of Cytoreduction: CC score Completeness of cytoreduction is the most important prognostic factor after CRS. Residual disease after CRS…
Study [Reference] No. (PSM origin) Drugs Operative time (min) HIPEC duration (min) Hospital stay (days) Mortality Morbidity Ascites resolution Median survival (months) Chang et al. 2001 [33] 2 (1 MPM,…
Year 2012 Description Age 0–44 45–54 55–64 65–74 75+ Total Malignant neoplasm of peritoneum or retroperitoneum (primary) 133 264 518 665 732 2,312 Malignant neoplasm of peritoneum or retroperitoneum (secondary)…
Procedural safety recommendations Surgical field Use of disposable drapes (not textile cloth) Operating room Closed door, access restriction, prevent of possible spills Caregivers Disposable impervious gown and shoe covers; double…
Grade I: Events carrying minor risks; complication, if left untreated, resolves spontaneously or at most requires a simple bedside procedure. Analgesics, antipyretics, antiemetics, antibiotics orally, and antidiarrheals are permitted Grade…
34. Helm CW, Randall-Whitis L, Martin RS et al (2007) Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma. Gynecol Oncol 105:90–96CrossRefPubMed 35. Cotte E,…
